I now have rich, comprehensive content from Bailey & Love and Cummings. I have enough material to write a detailed 20-mark MS ENT university exam answer. Let me compose it now.
GOITRE: CLASSIFICATION AND MANAGEMENT
MS ENT University Examination Answer (20 Marks)
DEFINITION
The term goitre (Latin: guttur = throat) refers to a generalised enlargement of the thyroid gland. A discrete swelling in one lobe with no palpable abnormality elsewhere is an isolated (solitary) swelling, while discrete swellings with evidence of abnormality elsewhere in the gland are termed dominant swellings.
The normal thyroid gland is impalpable; any palpable enlargement warrants investigation.
CLASSIFICATION OF GOITRE
I. BASED ON THYROID FUNCTION (Clinical Classification)
| Type | Subtypes |
|---|
| Euthyroid (Simple) | Diffuse hyperplastic, Multinodular |
| Toxic (Hyperthyroid) | Diffuse (Graves' disease), Toxic multinodular, Toxic adenoma |
| Hypothyroid | Hashimoto's thyroiditis, Dyshormonogenesis |
II. BASED ON PATHOLOGICAL/STRUCTURAL TYPE (Bailey & Love, Table 55.3)
| Category | Type | Examples |
|---|
| Simple Goitre (Euthyroid) | Diffuse hyperplastic | Physiological, Pubertal, Pregnancy |
| Multinodular goitre | - |
| Toxic | Diffuse | Graves' disease |
| Multinodular | Toxic MNG |
| Adenoma | Toxic adenoma (Plummer's disease) |
| Neoplastic | Benign | Follicular adenoma |
| Malignant | PTC, FTC, MTC, ATC, Lymphoma |
| Inflammatory | Autoimmune | Chronic lymphocytic thyroiditis, Hashimoto's disease |
| Granulomatous | de Quervain's thyroiditis |
| Fibrosing | Riedel's thyroiditis |
| Infective | Acute bacterial/viral; Chronic (TB, syphilitic) |
| Other | Amyloid |
III. WHO GRADING OF GOITRE (for field surveys / epidemiology)
| Grade | Description |
|---|
| Grade 0 | No goitre (thyroid not visible or palpable) |
| Grade 1 | Goitre palpable but not visible with neck in normal position |
| Grade 2 | Goitre clearly visible with neck in normal position |
(Simplified WHO 2001 classification replaces the older Grades 0-III system)
IV. BASED ON EPIDEMIOLOGY
- Endemic goitre - affects >10% of a population in a defined geographical area, mainly due to iodine deficiency. Common in mountainous regions (Alps, Himalayas, Andes, Rocky Mountains, Derbyshire/Yorkshire in UK).
- Sporadic goitre - occurs outside endemic areas; often due to dyshormonogenesis, goitrogens, or autoimmune causes.
V. BASED ON ANATOMICAL EXTENT
- Cervical goitre - confined to the neck
- Retrosternal (substernal) goitre - extends below the thoracic inlet into the mediastinum
- Plunging goitre - intermittently descends into the chest with valsalva; returns on swallowing
- Wandering goitre - rare; loses all connection with the cervical gland
AETIOLOGY OF SIMPLE GOITRE
- Iodine deficiency - most important in endemic goitre; daily requirement ~0.1-0.15 mg iodine. Iodine-poor areas include mountainous ranges and areas with calcium-rich limestone soil (goitrogenic effect).
- TSH stimulation - chronic low circulating thyroid hormones stimulate TSH secretion, driving thyroid follicular cell proliferation.
- Dyshormonogenesis - enzyme deficiencies (often genetic) impairing thyroid hormone synthesis, causing TSH elevation and gland enlargement.
- Goitrogens - dietary (cassava, brassica family - cabbage, turnips), drugs (lithium, amiodarone, propylthiouracil, carbimazole), excess iodine (Wolff-Chaikoff effect).
- Immunoglobulins and growth factors - heterogeneous structural response leading to characteristic nodularity; certain clones of cells are particularly sensitive to growth stimulation, explaining nodule formation.
CLINICAL FEATURES
Symptoms:
- Neck swelling - moves up on swallowing (key sign: attached to trachea or thyroid)
- Pressure symptoms: dysphagia, stridor, dyspnoea, hoarseness (RLN compression/invasion)
- Features of hypo/hyperthyroidism depending on type
- Pemberton's sign - elevation of both arms causes facial flushing/venous engorgement/stridor (retrosternal goitre)
Signs:
- Cervical swelling moving on deglutition
- Tracheal deviation
- Retrosternal dullness
- Features of toxicity (tremor, exophthalmos, tachycardia) if toxic goitre
- Vocal cord assessment on laryngoscopy
INVESTIGATIONS
1. Thyroid Function Tests (TFT)
- TSH (most sensitive screening test), Free T3, Free T4
- Exclude hypo/hyperthyroidism
2. Thyroid Antibodies
- Anti-TPO, Anti-thyroglobulin - differentiate autoimmune thyroiditis from simple goitre
3. Ultrasonography (USG)
- Gold standard for nodule assessment when performed by trained operator
- Determines: number, size, echotexture, cystic vs. solid, vascularity (Doppler), suspicious features (microcalcifications, taller-than-wide shape, ill-defined margins, hypoechogenicity)
- Assesses: extent of enlargement, retrosternal extension, tracheal deviation/narrowing
- Multiple isoechoic nodules with cystic change in both lobes = almost certainly benign MNG
- Outperforms CT and MRI for nodule characterisation
4. Fine Needle Aspiration Cytology (FNAC)
- Required only for nodules demonstrating suspicious ultrasonographic features
- Must be done under ultrasound guidance to target the correct nodule
- UK/British reporting (Thy classification):
| Grade | Interpretation |
|---|
| Thy1 | Non-diagnostic |
| Thy1c | Non-diagnostic cystic |
| Thy2 | Non-neoplastic (benign) |
| Thy3 | Follicular lesion (indeterminate) |
| Thy4 | Suspicious of malignancy |
| Thy5 | Malignant |
5. CT Scan of Neck and Chest
- Indicated when swallowing/breathing symptoms are present
- Best for assessing: tracheal deviation, oesophageal compression, retrosternal extension, extent of disease
- Note: CT arms-up position may underestimate retrosternal extent - surgeon must be aware of patient positioning during interpretation
6. Flexible Laryngoscopy
- Preoperative assessment of vocal cord mobility (mandatory before thyroid surgery)
- Unilateral cord palsy + ipsilateral suspicious nodule = highly suggestive of malignancy
7. Radioactive Iodine Scan (99mTc or 131I)
- Hot, warm, or cold nodule assessment
- Cold nodule has higher risk of malignancy (~10-15%)
- Useful for toxic nodules
8. Serum Calcitonin
- Elevated in medullary thyroid carcinoma (MTC)
- Some guidelines recommend routine testing for all thyroid nodules
MANAGEMENT
A. MEDICAL MANAGEMENT
1. Iodine supplementation (Endemic goitre)
- Iodised salt - has strikingly reduced the incidence of endemic goitre worldwide
- Potassium iodide supplementation
2. Thyroxine suppression therapy
- In early hyperplastic goitre: L-thyroxine 0.15-0.2 mg/day for a few months may cause regression
- The nodular stage is largely irreversible - thyroxine has limited benefit in MNG
- More than half of benign nodules regress in size over 10 years (spontaneous regression)
- Caution: TSH suppression risks osteoporosis and atrial fibrillation, especially in elderly
3. Radioactive Iodine (131I)
- Alternative to surgery in toxic MNG or Graves' disease in patients unfit for surgery
- May also reduce size of non-toxic goitre by ~30-40%
- Contraindicated in pregnancy, suspected malignancy, very large goitres causing compression
- Risk of radiation thyroiditis, transient worsening of symptoms
4. Management of goitrogen exposure
- Stop offending drug if possible; substitute alternative medications
B. SURGICAL MANAGEMENT
Indications for Surgery in Goitre
- Suspected malignancy - FNAC Thy4 or Thy5, suspicious USG features, dominant/rapidly growing nodule
- Follicular neoplasm (Thy3) - all should be excised as cytology cannot distinguish follicular adenoma from carcinoma
- Pressure symptoms - dysphagia, stridor, dyspnoea not responding to medical therapy
- Retrosternal/substernal extension - especially if symptomatic or in young patients
- Toxic goitre - Graves' disease or toxic MNG unresponsive or unsuitable for medical/radioiodine treatment
- Cosmetic disfigurement - if significant
- Patient preference after adequate counselling
Contraindications/Relative Caution
- Elderly patients with incidentally discovered retrosternal goitre - may observe rather than treat prophylactically
Types of Thyroid Surgery
| Operation | Definition |
|---|
| Total lobectomy (hemithyroidectomy) | Removal of one lobe |
| Isthmusectomy | Removal of isthmus |
| Subtotal lobectomy | Partial removal of one lobe |
| Lobectomy | Total lobectomy + isthmusectomy |
| Subtotal thyroidectomy | 2x subtotal lobectomy + isthmusectomy |
| Near-total (Dunhill procedure) | Total lobectomy + isthmusectomy + subtotal lobectomy |
| Total thyroidectomy | 2x total lobectomy + isthmusectomy |
Surgery for Specific Conditions
Simple/Toxic MNG:
- Near-total or total thyroidectomy preferred
- Reduces recurrence risk vs. subtotal approach
- Total thyroidectomy: immediate control of toxicity, 100% risk of hypothyroidism (thyroid replacement mandatory), 5% permanent hypoparathyroidism
- Subtotal thyroidectomy: variable return to euthyroid (up to 12 months), lifelong risk of recurrence (~5%) and late failure (up to 100% at 30 years)
Graves' Disease:
- Surgery after achieving euthyroid state with antithyroid drugs (carbimazole/PTU)
- Total vs. subtotal thyroidectomy comparison (see table above)
- Total thyroidectomy preferred in most modern practice
Retrosternal Goitre:
- Vast majority (>95%) can be removed via transcervical (collar) incision
- Blood supply originates in the neck - ligate, divide, then use gentle blunt finger dissection to free mediastinal component
- Division of isthmus may facilitate delivery
- Sternotomy required for: malignant disease, previous thyroid operations, no cervical thyroid tissue, goitre diameter exceeding thoracic inlet, posterior mediastinal extension
- Joint planning with thoracic surgery in high-risk cases
Complications of Thyroid Surgery
Immediate (intraoperative/within 24 hours):
- Haemorrhage/haematoma - can cause acute airway compromise (emergency: open wound at bedside)
- RLN injury - unilateral: hoarseness; bilateral: stridor, emergency tracheostomy
- Wound infection
Early (24 hours to 2 weeks):
- Hypocalcaemia (hypoparathyroidism) - tetany, Chvostek's/Trousseau's signs; treat with IV calcium gluconate acutely, then oral calcium/vitamin D
- Seroma
Late:
- Hypothyroidism (requires lifelong thyroxine replacement)
- Recurrent hyperthyroidism (after subtotal resection)
- Keloid scar
- Superior laryngeal nerve (external branch) injury - loss of high-pitched voice, fatigue of voice
RETROSTERNAL GOITRE - SPECIAL NOTE (Common ENT Exam Topic)
- Defined as thyroid enlargement that extends below the thoracic inlet into the superior mediastinum
- Incidence: <1% of all goitres have significant intrathoracic extension
- Blood supply: from superior and inferior thyroid arteries in the neck (not from mediastinal vessels) - this is why transcervical removal is almost always possible
- Symptoms: dysphagia, dyspnoea, stridor, facial oedema, SVCO features
- Pemberton's sign - raised arms causes venous obstruction and facial flushing
- Investigation: CT scan (defines extent, tracheal compression, vascular relationships)
- Management: surgery via collar incision; sternotomy reserved for special situations (see above)
COMPLICATIONS OF UNTREATED GOITRE
- Tracheal obstruction - lateral displacement or anteroposterior compression; retrosternal extension impacting thoracic inlet
- Acute respiratory obstruction - haemorrhage into a nodule causing sudden enlargement
- Secondary thyrotoxicosis - transient hyperthyroid episodes occur in up to 30% of MNG patients
- Carcinoma - increased incidence (usually follicular) in endemic areas and longstanding nodular goitres. Dominant or rapidly growing nodules must always be aspirated
- Dysphagia - oesophageal compression
- SVCO - superior vena cava obstruction (retrosternal goitre)
- Recurrent laryngeal nerve palsy
SUMMARY TABLE FOR QUICK REVISION
| Feature | Simple Goitre | Toxic MNG | Malignant Nodule |
|---|
| TFTs | Normal | TSH low, T3/T4 high | Usually normal |
| Antibodies | Negative | Negative | Negative (usually) |
| USG | Multiple isoechoic nodules, cystic change | Multiple nodules, hot spots | Hypoechoic, microcalcifications, taller-than-wide, ill-defined |
| FNAC | Thy2 | Thy2 | Thy4/Thy5 |
| Treatment | Observe / T4 / iodine | ATDs, then surgery/RAI | Surgery |
References:
- Bailey and Love's Short Practice of Surgery, 28th Edition (Chapter 55: Thyroid)
- Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 1
- Cummings Otolaryngology Head and Neck Surgery, 7th Edition
- Sabiston Textbook of Surgery